Leslie Skeith, MD, MHPE, FRCPC: CSL Behring: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); LEO Pharma: Speaker/Honoraria (Ongoing)
Learning Objectives / Objectifs d'apprentissage:
At the end of this session participants will be able to / Au terme de cette conférence, vous serez:
interpret the latest evidence for prevention of VTE in pregnancy and the postpartum period;
determine an approach for treatment of VTE during pregnancy; and
describe areas of uncertainty and future research directions.
VTE during pregnancy and in the post-partum period require consideration of specific factors and prevention and treatment approaches. This session will review the latest data, and discuss areas for future research.